BTG plc (BTG) Earns Hold Rating from Numis Securities Ltd
A number of other research analysts also recently issued reports on BTG. Royal Bank Of Canada increased their price objective on BTG plc from GBX 820 ($10.15) to GBX 890 ($11.01) and gave the stock an outperform rating in a report on Wednesday, June 8th. Deutsche Bank AG reissued a buy rating and set a GBX 740 ($9.16) price target on shares of BTG plc in a research report on Wednesday, June 15th. Stifel Nicolaus reissued a buy rating on shares of BTG plc in a research report on Friday, June 24th. Jefferies Group increased their price target on BTG plc from GBX 840 ($10.40) to GBX 860 ($10.64) and gave the company a buy rating in a research report on Wednesday, June 29th. Finally, JPMorgan Chase & Co. reduced their price target on BTG plc from GBX 800 ($9.90) to GBX 790 ($9.78) and set a neutral rating for the company in a research report on Friday, July 15th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of GBX 799.57 ($9.90).
Shares of BTG plc (LON:BTG) opened at 701.00 on Thursday. BTG plc has a one year low of GBX 504.00 and a one year high of GBX 739.50. The stock’s 50 day moving average price is GBX 633.03 and its 200 day moving average price is GBX 642.16. The firm’s market capitalization is GBX 2.68 billion.
In other news, insider Soderstrom,Rolf sold 74,327 shares of the firm’s stock in a transaction that occurred on Thursday, July 21st. The stock was sold at an average price of GBX 676 ($8.37), for a total value of £502,450.52 ($621,844.70).
About BTG plc
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.